Literature DB >> 35576512

Increased levels of pathogenic Th17 cells and diminished function of CD69+ Treg lymphocytes in patients with overweight.

Alejandra Mendoza-Pérez1,2, Marlen Vitales-Noyola1, Larisa González-Baranda1,3, Crisol Álvarez-Quiroga1, Berenice Hernández-Castro1,2, Adriana Monsiváis-Urenda1,2, Lourdes Baranda1,2,3, Perla Niño-Moreno1, Gilberto Hurtado3, Raquel Sánchez-Gutiérrez1,2, Roberto González-Amaro1,2.   

Abstract

A low-grade inflammatory phenomenon is a feature of overweight and metabolic syndrome. The involvement of a pro-inflammatory Th17 lymphocyte subset and the CD69+ T regulatory (Treg) cell subtype in patients with metabolic dysfunction associated with or without overweight has not been fully elucidated. The aim of this study was to perform a quantitative and functional analysis of pathogenic Th17 lymphocytes and CD69+ Treg cells in patients with metabolic dysfunction (insulin resistance and dyslipidemia). The number of pathogenic Th17 cells and the levels and function of CD69+ Treg cells were analyzed in blood samples from individuals with metabolic dysfunction, associated with or without overweight. Pathogenic and non-pathogenic Th17 lymphocytes as well as Th22 cells were determined by eight-color flow cytometry analysis, whereas the levels and suppressive function of CD69+ Treg cells were also analyzed by multiparametric flow cytometry. We detected increased levels of pro-inflammatory Th17 pathogenic cells and Th22 lymphocytes in overweight unhealthy individuals (P < 0.001, compared to normal weight healthy). Conversely, diminished numbers of CD69+ Treg lymphocytes were observed in metabolically unhealthy individuals, with or without overweight. Likewise, the immunosuppressive function of CD69+ Treg cells was also defective in these patients. The increased levels of pathogenic Th17 cells along with a diminished number and function of CD69+ Treg lymphocytes may significantly contribute to the low-grade inflammatory phenomenon of metabolically unhealthy patients.
© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  immune regulation; interleukin-17; lymphocytes; metabolic syndrome

Mesh:

Year:  2022        PMID: 35576512      PMCID: PMC9307236          DOI: 10.1093/cei/uxac051

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   5.732


  30 in total

Review 1.  Role of innate and adaptive immunity in obesity-associated metabolic disease.

Authors:  Tracey McLaughlin; Shelley E Ackerman; Lei Shen; Edgar Engleman
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

Review 2.  Inflammation of brown/beige adipose tissues in obesity and metabolic disease.

Authors:  F Villarroya; R Cereijo; A Gavaldà-Navarro; J Villarroya; M Giralt
Journal:  J Intern Med       Date:  2018-07-16       Impact factor: 8.989

3.  Regulatory T Cells and Human Disease.

Authors:  Shimon Sakaguchi; Norihisa Mikami; James B Wing; Atsushi Tanaka; Kenji Ichiyama; Naganari Ohkura
Journal:  Annu Rev Immunol       Date:  2020-02-04       Impact factor: 28.527

4.  The immunogenetic diversity of the HLA system in Mexico correlates with underlying population genetic structure.

Authors:  Rodrigo Barquera; Diana Iraíz Hernández-Zaragoza; Alicia Bravo-Acevedo; Esteban Arrieta-Bolaños; Stephen Clayton; Víctor Acuña-Alonzo; Julio César Martínez-Álvarez; Concepción López-Gil; Carmen Adalid-Sáinz; María Del Rosario Vega-Martínez; Araceli Escobedo-Ruíz; Eva Dolores Juárez-Cortés; Alexander Immel; Hanna Pacheco-Ubaldo; Liliana González-Medina; Abraham Lona-Sánchez; Julio Lara-Riegos; María Guadalupe de Jesús Sánchez-Fernández; Rosario Díaz-López; Gregorio Ulises Guizar-López; Carolina Elizabeth Medina-Escobedo; María Araceli Arrazola-García; Gustavo Daniel Montiel-Hernández; Ofelia Hernández-Hernández; Flor Del Rocío Ramos-de la Cruz; Francisco Juárez-Nicolás; Jorge Arturo Pantoja-Torres; Tirzo Jesús Rodríguez-Munguía; Vicencio Juárez-Barreto; Héctor Delgado-Aguirre; Ariadna Berenice Escutia-González; Isis Goné-Vázquez; Gamaliel Benítez-Arvizu; Francia Paulina Arellano-Prado; Víctor Eduardo García-Arias; Marla Estefanía Rodríguez-López; Patricia Méndez-Mani; Raquel García-Álvarez; Marisela Del Rocío González-Martínez; Guadalupe Aquino-Rubio; Néstor Escareño-Montiel; Tannya Verónica Vázquez-Castillo; María Guadalupe Uribe-Duarte; María de Jesús Ruíz-Corral; Andrea Ortega-Yáñez; Natalia Bernal-Felipe; Benjamín Gómez-Navarro; Agustín Jericó Arriaga-Perea; Virginia Martínez-Bezies; Rosa María Macías-Medrano; Jesús Abraham Aguilar-Campos; Raúl Solís-Martínez; Ricardo Serrano-Osuna; Mario J Sandoval-Sandoval; Yolanda Jaramillo-Rodríguez; Antonio Salgado-Adame; Federico Juárez-de la Cruz; Bárbara Novelo-Garza; María de Los Ángeles Pavón-Vargas; Norma Salgado-Galicia; Maria Cátira Bortolini; Carla Gallo; Gabriel Bedoya; Francisco Rothhammer; Rolando González-José; Andrés Ruiz-Linares; Samuel Canizales-Quinteros; Sandra Romero-Hidalgo; Johannes Krause; Joaquín Zúñiga; Edmond J Yunis; Carolina Bekker-Méndez; Julio Granados
Journal:  Hum Immunol       Date:  2020-07-08       Impact factor: 2.850

Review 5.  Cytokine-regulated Th17 plasticity in human health and diseases.

Authors:  Silvia Cerboni; Ulf Gehrmann; Silvia Preite; Suman Mitra
Journal:  Immunology       Date:  2020-11-06       Impact factor: 7.397

6.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.

Authors:  Claire L Langrish; Yi Chen; Wendy M Blumenschein; Jeanine Mattson; Beth Basham; Jonathan D Sedgwick; Terrill McClanahan; Robert A Kastelein; Daniel J Cua
Journal:  J Exp Med       Date:  2005-01-17       Impact factor: 14.307

7.  Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids.

Authors:  Radha Ramesh; Lina Kozhaya; Kelly McKevitt; Ivana M Djuretic; Thaddeus J Carlson; Maria A Quintero; Jacob L McCauley; Maria T Abreu; Derya Unutmaz; Mark S Sundrud
Journal:  J Exp Med       Date:  2014-01-06       Impact factor: 14.307

8.  Patients with Systemic Lupus Erythematosus Show Increased Levels and Defective Function of CD69+ T Regulatory Cells.

Authors:  Marlen Vitales-Noyola; Brenda Oceguera-Maldonado; Perla Niño-Moreno; Nubia Baltazar-Benítez; Lourdes Baranda; Esther Layseca-Espinosa; Carlos Abud-Mendoza; Roberto González-Amaro
Journal:  Mediators Inflamm       Date:  2017-09-06       Impact factor: 4.711

Review 9.  The roles of T cells in obese adipose tissue inflammation.

Authors:  Qiong Wang; Yurong Wang; Danyan Xu
Journal:  Adipocyte       Date:  2021-12       Impact factor: 4.534

Review 10.  Role of Th22 Cells in the Pathogenesis of Autoimmune Diseases.

Authors:  Qi Jiang; Guocan Yang; Fan Xiao; Jue Xie; Shengjun Wang; Liwei Lu; Dawei Cui
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.